Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant
Completed
Conditions studied: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Nonmalignant Neoplasm
In brief
RATIONALE: Studying immune response to flu vaccine in patients who have undergone a stem cell transplant may help doctors plan the best treatment. PURPOSE: This clinical trial is studying flu vaccine to see how well it works in preventing infection in patients who have undergone a stem cell transplant and in healthy volunteers.
Key facts
- Study ID
- NCT00964821
- Run by
- City of Hope Medical Center
- People needed
- 459
- Starts
- 2007-01-01
- Expected to finish
- 2013-05-01
- Last updated by the study team
- 2017-11-07
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: accepted.
Where it is running
- City of Hope Comprehensive Cancer Center — Duarte, California, United States
- City of Hope Medical Group — Pasadena, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.